1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Chase Heaton, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat ImmunoPulse, Epacadostat, Pembrolizumab - Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 2 | Terminated | Chase Heaton, MD | 14 | 2019-05-02 | 2023-05-09 |
Squamous Cell Carcinoma of Head and Neck (1)
Electroporation (1) · Electroporation Therapies (1) · epacadostat (1) · pembrolizumab (1)
United States (1)